ASRV
AmeriServ Financial, Inc.
There isn't enough reported data to score ASRV yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
ASRV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
ASRV's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ASRV.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
ASRV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.6x | $4.39 | -7.2% |
| Current | 9.3x | $4.73 | — |
| Fair | 11x | $5.51 | +17% |
| Expensive | 14x | $6.89 | +46% |
Historical ranges are pointers, not guarantees.
ASRV has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
ASRV Forward outlook
There aren't enough analyst estimates for ASRV to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
ASRV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.51 | +132% |
| Q1 2026 | $0.33 | +50% |
| Q4 2025 | $0.34 | +62% |
| Q3 2025 | $0.30 | +$0.45 |
| Q2 2025 | $0.22 | +$0.40 |
| Q1 2025 | $0.22 | +$0.39 |
| Q4 2024 | $0.21 | +$0.40 |
| Q3 2024 | -$0.15 | -183% |
ASRV earned $0.51 per share over the past year, up 132% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over ASRV on earnings, with more consistent year-over-year improvement.
ASRV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $22.7M | +4% |
| Q1 2026 | $21.5M | +1.5% |
| Q4 2025 | $15.3M | +9.4% |
| Q3 2025 | $22.9M | +9.4% |
| Q2 2025 | $21.8M | +4.3% |
| Q1 2025 | $21.1M | +54% |
| Q4 2024 | $14M | +23% |
| Q3 2024 | $20.9M | +60% |
ASRV has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 15% | +17 points |
| Q1 2026 | 10% | -0.9 points |
| Q4 2025 | 11% | +3.3 points |
| Q3 2025 | 13% | +6.7 points |
| Q2 2025 | -1.6% | +0.7 points |
| Q1 2025 | 11% | -6.1 points |
| Q4 2024 | 7.7% | +68 points |
| Q3 2024 | 6.8% | +0.9 points |
ASRV's operating margin was 15% last quarter, up 17 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over ASRV on profitability, with a higher operating margin.
ASRV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.1M | -$1.1M |
| Q1 2026 | $356K | -41% |
| Q3 2025 | $1.4M | +$2.4M |
| Q2 2025 | -$62K | -105% |
| Q1 2025 | $599K | +$3.4M |
| Q4 2024 | $3.6M | +388% |
| Q3 2024 | -$1M | -145% |
| Q2 2024 | $1.2M | +159% |
ASRV has the stronger cash trend. Its trailing FCF is down 81% versus its history, compared with JPM at down 229%.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
ASRV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +37.5K shares |
| 1 year | +2.7% | +447K shares |
| 3 years | -1.1% | -181K shares |
| 5 years | -1% | -165K shares |
| Available history | -2.3% | -394K shares |
ASRV has 17M diluted shares, up 2.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $151,000 |
| Q4 2019 | $384,000 |
| Q3 2019 | $1M |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over ASRV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
ASRV Net Leverage
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
ASRV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.6 | Neutral |
| Stochastic | 55.0 | Neutral |
ASRV's weekly RSI is 58 (neutral) and its Stochastic is 55 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
ASRV PE vs Financial Services Sector
| Metric | ASRV | Sector median | Relative |
|---|---|---|---|
| PE | 9.3x | 13x | 29% below |
| PE % | 28 | 63 | 35 pts below |
ASRV has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
ASRV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.68 | 1.1% above |
| 20 week MA | $4.62 | 2.4% above |
| 50 week MA | $4.02 | 18% above |
| 100 week MA | $3.40 | 39% above |
| 200 week MA | $3.14 | 51% above |
ASRV has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
ASRV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.24 | $3.30 | -22% |
| 2021 | $3.30 | $3.85 | +17% |
| 2022 | $3.85 | $3.99 | +3.6% |
| 2023 | $3.99 | $3.24 | -19% |
| 2024 | $3.24 | $2.58 | -20% |
| 2025 | $2.58 | $3.17 | +23% |
| 2026 YTD | $3.17 | $4.73 | +49% |
ASRV has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.